AMDCP Credit Designation: This session has been approved for a total of 1.5 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): David Polakoff, MD, MSc,CMD; Stefan Gravenstein, MD, MPH, CMD Disclosure(s): David Polakoff, MD, MSc, CMD receives honorarium from the following companies: Merck & Co., Schering-Plough, and Pfizer. He receives consultant fees from Iroko Pharmaceuticals StefanGravenstein, MD, MPH, CMD has no relevant financial relationships to disclose. Session Description: This session presents a review of the steps and barriers toperforming quality improvement work using research tools to elevate the qualityof the intervention assessments, and discusses what preparation is needed incase the work can be published. Learning Objectives:
Discuss when QI work in long term care should be considered researchthat needs a formal review ("IRB") and approval
Describe basics of selecting the right measurement and analysis toolsfor your project
Review resources available to accelerate your research process
Discuss guidelines and preparation for disseminating the successstories of your quality improvement work
References: Casarett D, Karlawish J, Sugarman J. Determining When QualityImprovement Initiatives Should Be Considered Research. JAMA.2000;283:2275-2280. Pronovost P, NeedhamD, Berenholtz S, et al. An intervention to decrease catheter-relatedbloodstream infections in the ICU. N Engl J Med 2006;355:2725-2732. Baily MA, Harming through Protection? N Engl J Med 2008;358:768-769. http://www.ahrq.gov/research/p... accessed July 7,2008. Miller FG, Emanuel EJ. Quality-Improvement Research andInformed Consent. N Engl J Med 2008; 358:765-767.